Mehra et al. studied seven ESC-RCCs and found biallelic loss of TSC1 or TSC2 in six of the seven cases, with evidence of mTOR activation by IHC, leading the authors to conclude that there is a pathognomic role for TSC mutations in ESC-RCC [47]. Here, MTOR is linked to renal cell carcinoma.